{"id":"https://openalex.org/W4411908249","doi":"https://doi.org/10.1158/1078-0432.29444530","title":"Supplementary Table S3 from Effective TIL Therapy for Patients with Checkpoint-Resistant Melanoma without Lymphodepleting Regimens Requires IFN\u03b1","display_name":"Supplementary Table S3 from Effective TIL Therapy for Patients with Checkpoint-Resistant Melanoma without Lymphodepleting Regimens Requires IFN\u03b1","publication_year":2025,"publication_date":"2025-07-01","ids":{"openalex":"https://openalex.org/W4411908249","doi":"https://doi.org/10.1158/1078-0432.29444530"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.29444530","doi":"https://doi.org/10.1158/1078-0432.29444530","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.29444530","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/1078-0432.29444530","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5059138103","display_name":"Els M.E. Verdegaal","orcid":"https://orcid.org/0000-0002-4449-8707","observed_orcids":["https://orcid.org/0000-0002-4449-8707"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Els M.E. Verdegaal","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-4449-8707","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5117449271","display_name":"Anique L.C. Verpoorte","orcid":"https://orcid.org/0009-0008-7722-1609","observed_orcids":["https://orcid.org/0009-0008-7722-1609"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anique L.C. Verpoorte","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0008-7722-1609","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061860913","display_name":"Monique K. van der Kooij","orcid":"https://orcid.org/0000-0002-9764-5467","observed_orcids":["https://orcid.org/0000-0002-9764-5467"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Monique K. van der Kooij","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-9764-5467","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050294061","display_name":"Linda de Bruin","orcid":"https://orcid.org/0009-0001-5296-7542","observed_orcids":["https://orcid.org/0009-0001-5296-7542"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Linda de Bruin","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0001-5296-7542","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078026201","display_name":"Marten Visser","orcid":"https://orcid.org/0000-0002-8544-131X","observed_orcids":["https://orcid.org/0000-0002-8544-131X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Marten Visser","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-8544-131X","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023896452","display_name":"Caroline E. van der Minne","orcid":"https://orcid.org/0009-0004-8345-2009","observed_orcids":["https://orcid.org/0009-0004-8345-2009"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Caroline E. van der Minne","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0004-8345-2009","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091053687","display_name":"Vera Weeda","orcid":"https://orcid.org/0009-0008-1537-0342","observed_orcids":["https://orcid.org/0009-0008-1537-0342"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Vera Weeda","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0008-1537-0342","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041980286","display_name":"Inge C.F.M. Roozen","orcid":"https://orcid.org/0009-0006-1352-5684","observed_orcids":["https://orcid.org/0009-0006-1352-5684"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Inge C.F.M. Roozen","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0006-1352-5684","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064422052","display_name":"Mare A. Jonker","orcid":"https://orcid.org/0009-0004-9053-5945","observed_orcids":["https://orcid.org/0009-0004-9053-5945"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mare A. Jonker","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0004-9053-5945","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113777303","display_name":"Inge M. Westra","orcid":"https://orcid.org/0009-0009-3271-495X","observed_orcids":["https://orcid.org/0009-0009-3271-495X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Inge M. Westra","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0009-3271-495X","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059973952","display_name":"Pauline Meij","orcid":"https://orcid.org/0000-0003-3370-9932","observed_orcids":["https://orcid.org/0000-0003-3370-9932"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Pauline Meij","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-3370-9932","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067669644","display_name":"Frank M. Speetjens","orcid":"https://orcid.org/0000-0003-2065-9593","observed_orcids":["https://orcid.org/0000-0003-2065-9593"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Frank M. Speetjens","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-2065-9593","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5117449270","display_name":"Stephanie M. Zunder","orcid":"https://orcid.org/0009-0000-5550-3383","observed_orcids":["https://orcid.org/0009-0000-5550-3383","https://orcid.org/0000-0002-0595-583X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Stephanie M. Zunder","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0000-5550-3383","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031880856","display_name":"Gerrit\u2010Jan Liefers","orcid":"https://orcid.org/0000-0001-7326-8313","observed_orcids":["https://orcid.org/0000-0001-7326-8313"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gerrit-Jan Liefers","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-7326-8313","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032553128","display_name":"Saskia J A M Santegoets","orcid":"https://orcid.org/0000-0002-2874-4402","observed_orcids":["https://orcid.org/0000-0002-2874-4402"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Saskia J. Santegoets","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-2874-4402","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041281028","display_name":"Sjoerd H. van der Burg","orcid":"https://orcid.org/0000-0002-6556-0354","observed_orcids":["https://orcid.org/0000-0002-6556-0354"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sjoerd H. van der Burg","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-6556-0354","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5031300611","display_name":"Ellen Kapiteijn","orcid":"https://orcid.org/0000-0002-4814-6426","observed_orcids":["https://orcid.org/0000-0002-4814-6426"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ellen H.W. Kapiteijn","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-4814-6426","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9262999892234802,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9262999892234802,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.03819999843835831,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.01889999955892563,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tumor-infiltrating-lymphocytes","display_name":"tumor-infiltrating lymphocytes","score":0.9419999718666077},{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.7490000128746033},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.781000018119812},{"id":"https://openalex.org/keywords/interferon-alpha","display_name":"interferon-alpha","score":0.8989999890327454},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.8880000114440918},{"id":"https://openalex.org/keywords/treatment-safety","display_name":"treatment safety","score":0.5860000252723694}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5522685050964355},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.5117361545562744},{"id":"https://openalex.org/C45235069","wikidata":"https://www.wikidata.org/wiki/Q278425","display_name":"Table (database)","level":2,"score":0.4855034351348877},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.39153748750686646},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.33788639307022095},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.33137577772140503},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.21594691276550293},{"id":"https://openalex.org/C124101348","wikidata":"https://www.wikidata.org/wiki/Q172491","display_name":"Data mining","level":1,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1158/1078-0432.29444530","doi":"https://doi.org/10.1158/1078-0432.29444530","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.29444530","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/29444530","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Supplementary_Table_S3_from_Effective_TIL_Therapy_for_Patients_with_Checkpoint-Resistant_Melanoma_without_Lymphodepleting_Regimens_Requires_IFN_/29444530","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.29444530","doi":"https://doi.org/10.1158/1078-0432.29444530","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.29444530","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4410120590","https://openalex.org/W4411906836","https://openalex.org/W7043163971","https://openalex.org/W4361890508","https://openalex.org/W3213483706","https://openalex.org/W7154684293","https://openalex.org/W4410818214","https://openalex.org/W6991972722","https://openalex.org/W2895610076","https://openalex.org/W4361937644"],"abstract_inverted_index":{"Supplementary":[0],"Table":[1],"S3.":[2],"Safety":[3],"evaluation":[4],"of":[5],"all":[6],"adverse":[7],"events":[8],"and":[9],"relation":[10],"to":[11],"treatment.":[12]},"counts_by_year":[],"updated_date":"2026-09-26T08:19:03.415552","created_date":"2025-10-10T00:00:00"}